Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
Vlahovic G, Meadows KL, Hatch AJ, Jia J, Nixon AB, Uronis HE, Morse MA, Selim MA, Crawford J, Riedel RF, Zafar SY, Howard LA, O'Neill M, Meadows JJ, Haley ST, Arrowood CC, Rushing C, Pang H, Hurwitz HI. Vlahovic G, et al. Among authors: selim ma. Oncologist. 2018 Jul;23(7):782-790. doi: 10.1634/theoncologist.2016-0377. Epub 2018 Mar 23. Oncologist. 2018. PMID: 29572245 Free PMC article. Clinical Trial.
Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma.
Salama AKS, Palta M, Rushing CN, Selim MA, Linney KN, Czito BG, Yoo DS, Hanks BA, Beasley GM, Mosca PJ, Dumbauld C, Steadman KN, Yi JS, Weinhold KJ, Tyler DS, Lee WT, Brizel DM. Salama AKS, et al. Among authors: selim ma. Clin Cancer Res. 2021 Mar 1;27(5):1287-1295. doi: 10.1158/1078-0432.CCR-20-2452. Epub 2020 Nov 10. Clin Cancer Res. 2021. PMID: 33172894 Free PMC article.
A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity.
Beasley GM, Coleman AP, Raymond A, Sanders G, Selim MA, Peterson BL, Brady MS, Davies MA, Augustine C, Tyler DS. Beasley GM, et al. Among authors: selim ma. Ann Surg Oncol. 2012 Nov;19(12):3896-3905. doi: 10.1245/s10434-012-2373-8. Epub 2012 May 2. Ann Surg Oncol. 2012. PMID: 22549288 Free PMC article. Clinical Trial.
Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.
Agarwal A, Barrow W, Selim MA, Nicholas MW. Agarwal A, et al. Among authors: selim ma. JAMA Dermatol. 2016 Jul 1;152(7):842-4. doi: 10.1001/jamadermatol.2016.0503. JAMA Dermatol. 2016. PMID: 27028556 No abstract available.
220 results